ProBacLab, Department of Advanced Convergence, Handong Global University, Gyeongbuk, 37554, Pohang, Republic of Korea.
BLIS Technologies Ltd, 81 Glasgow Street, South Dunedin, 9012, New Zealand.
Probiotics Antimicrob Proteins. 2021 Dec;13(6):1499-1507. doi: 10.1007/s12602-021-09833-0. Epub 2021 Aug 13.
We are currently experiencing the realities of the most severe pandemic within living memory, with major impacts on the health and economic well-being of our planet. The scientific community has demonstrated an unprecedented mobilization capability, with the rapid development of vaccines and drugs targeting the protection of human life and palliative measures for infected individuals. However, are we adequately prepared for ongoing defense against COVID-19 and its variants in the post-pandemic world? Moreover, are we equipped to provide a satisfactory quality of life for individuals who are recovering from COVID-19 disease? What are the possibilities for the acceleration of the recovery process? Here, we give special consideration to the potential and already-demonstrated role of probiotics and traditional medical approaches to the management of current and potential future encounters with our major virus adversaries.
我们目前正在经历有记忆以来最严重的大流行病的现实，这场大流行病对我们地球的健康和经济福祉产生了重大影响。科学界展示了前所未有的动员能力，迅速开发出针对保护人类生命和为受感染个体提供缓解措施的疫苗和药物。然而，我们是否为在后疫情世界中持续防范 COVID-19 及其变体做好了充分准备？此外，我们是否有能力为从 COVID-19 疾病中康复的个人提供满意的生活质量？加快康复过程的可能性有哪些？在这里，我们特别考虑了益生菌和传统医疗方法在管理当前和潜在未来与我们主要病毒对手的接触方面的潜力和已经证明的作用。
